StockData

Establishment Labs vs Inogen

ESTA and INGN side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ESTA and INGN compare

Establishment Labs is the larger company, worth 14 times as much as Inogen ($2.1B against $151M).

Establishment Labs grew revenue faster over the last twelve months (38.3% versus 13.7% for Inogen).

Inogen keeps more of each dollar of sales as profit, with a net margin of −9.3% compared with −14.6% at Establishment Labs.

Inogen scores higher on the StockData Score (12 against 5 for Establishment Labs), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricESTAINGN
Size and price
Market cap$2.1B$151M
Share price$70.75$5.69
Change, 1 year12.0%−19.7%
Change, 5 years9.7%−82.8%
Beta (5Y)1.181.25
Employees1,004314
StockData Score
Total score512 (better)
Valuation score03 (better)
Growth score3 (better)1
Performance score13 (better)
Health score15 (better)
Dividend score00
Valuation
P/S8.0×0.4× (better)
P/B135×1.0× (better)
FCF yield−1.0% (better)−7.5%
Fair value–$17.93
Margin of safety–68.3%
Growth
Revenue growth (TTM)38.3% (better)13.7%
Revenue growth, 5Y average20.0% (better)2.5%
Profitability
Gross margin70.2% (better)44.1%
Operating margin−6.6% (better)−11.0%
Net margin−14.6%−9.3% (better)
FCF margin−8.2%−3.0% (better)
Return on equity−241%−20.0% (better)
Return on invested capital−6.7% (better)−49.2%
Financial health
Debt / equity17.17 (better)0.00
Interest coverage−0.6×–
Current ratio3.57 (better)2.96
Altman Z-score2.80 (better)1.30
Piotroski F-score35 (better)
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions95.8%72.9%
Held by insiders9.6%3.7%
Insider net buying, 12 months−$35.5M−$143K (better)
Short interest, % of float14.6%5.5%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.